Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.

Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.

Zobrazit další vydání (1)

BACKGROUND: Tumour necrosis factor (TNF)-alpha inhibitors are beneficial for the treatment of rheumatoid arthritis (RA) in terms of reducing the risk of joint damage, improving physical function and improving quality of life. This Cochrane review is an update of a review of the treatment of RA with...

Podrobná bibliografie
Hlavní autoři:	Ruiz Garcia, V, Jobanputra, P, Burls, A, Cabello, J, Vela Casasempere, P, Bort-Marti, S, Kynaston-Pearson, F
Médium:	Journal article
Jazyk:	English
Vydáno:	2014

Podobné jednotky

Certolizumab pegol (CDP870) for rheumatoid arthritis in adults.
Autor: Ruiz Garcia, V, a další
Vydáno: (2011)

Certolizumab pegol in therapy for rheumatoid arthritis
Autor: Galina Viktorovna Lukina, a další
Vydáno: (2012-06-01)

Certolizumab pegol (CIMZIA®) for the treatment of rheumatoid arthritis
Autor: M Connock, a další
Vydáno: (2010-10-01)

QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH CERTOLIZUMAB PEGOL
Autor: Vera Nikolayevna Amirdjanova, a další
Vydáno: (2012-10-01)

New aspects of the pharmacotherapy of rheumatoid arthritis: a focus on certolizumab pegol
Autor: Evgeniy L'vovich Nasonov, a další
Vydáno: (2011-02-01)

Multifocal tuberculosis on certolizumab pegol in a patient followed for rheumatoid arthritis
Autor: Emna Hannech, a další
Vydáno: (2021-06-01)

New treatment possibilities for rheumatoid arthritis: the Russian experience in using certolizumab pegol
Autor: Dmitry Evgenyevich Karateev, a další
Vydáno: (2012-04-01)

EFFICACY OF CERTOLIZUMAB PEGOL IN THE TREATMENT OF PSORIATIC ARTHRITIS
Autor: T. V. Korotaeva, a další
Vydáno: (2015-10-01)

Certolizumab pegol – new option in the treatment of psoriatic arthritis
Autor: Maria Majdan, a další
Vydáno: (2014-07-01)

Certolizumab pegol in the treatment of spondyloarthritis
Autor: Mariusz Korkosz
Vydáno: (2014-09-01)

Impact of high rheumatoid factor levels on treatment outcomes with certolizumab pegol and adalimumab in patients with rheumatoid arthritis
Autor: Smolen, JS, a další
Vydáno: (2024)

COST-EFFECTIVENESS OF CERTOLIZUMAB PEGOL PLUS METHOTREXATE OR AS MONOTHERAPY FOR THE TREATMENT OF ACTIVE RHEUMATOID ARTHRITIS IN THE UNITED KINGDOM
Autor: Purcaru, O, a další
Vydáno: (2010)

Prefilled certolizumab pegol (Cimzia&reg;) syringes for self-use in the treatment of rheumatoid arthritis
Autor: J Rosa, a další
Vydáno: (2010-08-01)

CERTOLIZUMAB PEGOL IN THE TREATMENT OF AXIAL SPONDYLOARTHRITIS
Autor: Sh. F. Erdes
Vydáno: (2016-02-01)

Eosinophilic Annular Erythema Due to Certolizumab Pegol Therapy for Rheumatoid Arthritis Post-COVID-19 Vaccine
Autor: Andrea Bassi, a další
Vydáno: (2023-04-01)

The efficacy of certolizumab pegol in rheumatoid arthritis assessed by gray scale and power Doppler ultrasonography: case reports
Autor: José Alexandre Mendonça, a další
Vydáno: (2019-02-01)

Exposure–Response Relationship of Certolizumab Pegol and Achievement of Low Disease Activity and Remission in Patients With Rheumatoid Arthritis
Autor: Stéphane Paul, a další
Vydáno: (2020-07-01)

Drug Induced Thrombotic Microangiopathy with Certolizumab Pegol
Autor: Mehmet Baysal, a další
Vydáno: (2018-09-01)

Treatment of pyoderma gangrenosum in pregnancy with certolizumab pegol
Autor: Lindsey J. Wanberg, a další
Vydáno: (2024-06-01)

Efficacy of certolizumab pegol across baseline rheumatoid factor subgroups in patients with rheumatoid arthritis: Post-hoc analysis of clinical trials
Autor: Tanaka, Y, a další
Vydáno: (2023)

Experience with long-term use of certolizumab pegol (Cimzia)
Autor: Karine Arnoldovna Lytkina, a další
Vydáno: (2013-10-01)

Experience with long-term use of certolizumab pegol (Cimzia)
Autor: Karine Arnoldovna Lytkina, a další
Vydáno: (2013-10-01)

A genome-wide screen for variants influencing certolizumab pegol response in a moderate to severe rheumatoid arthritis population.
Autor: Ian R White, a další
Vydáno: (2022-01-01)

A genome-wide screen for variants influencing certolizumab pegol response in a moderate to severe rheumatoid arthritis population
Autor: Ian R. White, a další
Vydáno: (2022-01-01)

Long-Term Durability of Certolizumab Pegol in Patients with Rheumatoid Arthritis Over 5 Years: An Analysis of Pooled Clinical Trial Data
Autor: Vivian P. Bykerk, a další
Vydáno: (2023-02-01)

Efficacy and safety of bimekizumab as add-on therapy for rheumatoid arthritis in patients with inadequate response to certolizumab pegol: a proof-of-concept study
Autor: Glatt, S, a další
Vydáno: (2019)

Quantitation of certolizumab pegol by validated liquid chromatography methods
Autor: Clóvis Dervil Appratto Cardoso Júnior, a další
Vydáno: (2023-11-01)

Certolizumab pegol in treatment of Crohn's disease with perianal lesions
Autor: I.L. Khalif, a další
Vydáno: (2018-04-01)

Active axial spondyloarthritis: potential role of certolizumab pegol
Autor: Ranatunga S, a další
Vydáno: (2014-02-01)

Certolizumab pegol w leczeniu reumatoidalnego zapalenia stawów
Autor: Piotr Wiland, a další
Vydáno: (2011-08-01)

An evidence-based review of certolizumab pegol in the treatment of active psoriatic arthritis: place in therapy
Autor: Acosta-Felquer ML, a další
Vydáno: (2016-03-01)

CERTOLIZUMAB PEGOL IN THE TREATMENT OF TAKAYASU ARTERITIS: THE FIRST EXPERIENCE AND PROSPECTS
Autor: P. I. Novikov, a další
Vydáno: (2018-07-01)

Physical function improvements and relief from fatigue and pain are associated with increased productivity at work and at home in rheumatoid arthritis patients treated with certolizumab pegol.
Autor: Hazes, J, a další
Vydáno: (2010)

Rapid effectiveness of certolizumab pegol in non-radiographic axial spondyloarthritis
Autor: A. Spadaro, a další
Vydáno: (2013-07-01)

Patient Adherence and Efficacy of Certolizumab Pegol in the Management of Crohn's Disease
Autor: Wojciech Blonski, a další
Vydáno: (2012-04-01)

Efficacy and tolerability of certolizumab pegol in Crohn's disease in clinical practice
Autor: O V Knyazev, a další
Vydáno: (2018-06-01)

Certolizumab pegol – Tumor necrosis factor inhibitor for refractory uveitis
Autor: Yael Sharon, a další
Vydáno: (2020-06-01)

Possible relationship between certolizumab pegol and arrhythmias: report of two cases
Autor: R. Talotta, a další
Vydáno: (2016-09-01)

Effectiveness of Certolizumab Pegol in Treating Rheumatoid Arthritis Patients with Persistent Inflamed Residual Mono- or Oligosynovitis Resistant to Prior TNF-α Inhibitors
Autor: Syuichi Koarada, a další
Vydáno: (2015-01-01)

Use of a baseline risk score to identify the risk of serious infectious events in patients with rheumatoid arthritis during certolizumab pegol treatment
Autor: Jeffrey R. Curtis, a další
Vydáno: (2017-12-01)